BP-C1 in the treatment of patients with stage IV breast cancer: a randomized, double-blind, placebo-controlled multicenter study and an additional open-label treatment phase

The aims were to compare the efficacy and tolerability of a new benzene-poly-carboxylic acids complex with cis-diammineplatinum (II) dichloride (BP-C1) versus placebo and to investigate the long-term tolerability of BP-C1 in the treatment of patients with metastatic breast cancer. MATERIAL AND METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsen, Stig, Butthongkomvong, Kritiya, Manikhas, Alexey, Trishkina, Ekaterina, Poddubuskaya, Elena, Matrosova, Marina, Srimuninnimit, Vichien, Lindkær-Jensen, Steen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251531/
https://www.ncbi.nlm.nih.gov/pubmed/25473312
http://dx.doi.org/10.2147/BCTT.S71781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4251531/
https://www.ncbi.nlm.nih.gov/pubmed/25473312
http://dx.doi.org/10.2147/BCTT.S71781

Ejemplares similares